Anniina Snellman

3.4k total citations · 2 hit papers
44 papers, 1.7k citations indexed

About

Anniina Snellman is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Anniina Snellman has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Physiology, 29 papers in Psychiatry and Mental health and 10 papers in Neurology. Recurrent topics in Anniina Snellman's work include Alzheimer's disease research and treatments (34 papers), Dementia and Cognitive Impairment Research (28 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Anniina Snellman is often cited by papers focused on Alzheimer's disease research and treatments (34 papers), Dementia and Cognitive Impairment Research (28 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). Anniina Snellman collaborates with scholars based in Finland, United Kingdom and Sweden. Anniina Snellman's co-authors include Kaj Blennow, Juan Lantero‐Rodriguez, Nicholas J. Ashton, Henrik Zetterberg, Thomas K. Karikari, Michael Schöll, Merja Haaparanta‐Solin, Pedro Rosa‐Neto, Tharick A. Pascoal and Juha O. Rinne and has published in prestigious journals such as Journal of Neuroscience, Brain and Neurology.

In The Last Decade

Anniina Snellman

43 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

2021 390 citations Nicholas J. Ashton, Tharick A. Pascoal et al. profile →
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

2020 218 citations Thomas K. Karikari, Andréa Lessa Benedet et al. Molecular Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anniina Snellman Finland	19	1.2k	830	394	307	165	44	1.7k
Richard Batrla Switzerland	15	1.2k 1.0×	906 1.1×	494 1.3×	339 1.1×	205 1.2×	24	2.4k
Nicholas K. Proctor United States	6	1.2k 1.1×	983 1.2×	365 0.9×	351 1.1×	163 1.0×	7	1.7k
Ronald Lautner Sweden	10	1.1k 0.9×	688 0.8×	533 1.4×	392 1.3×	260 1.6×	14	1.8k
Giuseppe Tosto United States	20	663 0.6×	547 0.7×	446 1.1×	319 1.0×	175 1.1×	66	1.5k
Mélissa Savard Canada	22	852 0.7×	592 0.7×	225 0.6×	283 0.9×	140 0.8×	51	1.3k
Min Su Kang Canada	23	1.1k 1.0×	793 1.0×	342 0.9×	323 1.1×	262 1.6×	67	1.8k
Hlin Kvartsberg Sweden	15	936 0.8×	580 0.7×	391 1.0×	320 1.0×	166 1.0×	39	1.3k
Niki S.M. Schoonenboom Netherlands	22	1.3k 1.1×	1.0k 1.3×	435 1.1×	530 1.7×	283 1.7×	37	2.1k
Nathalie Le Bastard Belgium	24	1.3k 1.1×	1.1k 1.4×	425 1.1×	306 1.0×	345 2.1×	61	2.0k
Mira Chamoun Canada	20	871 0.8×	664 0.8×	212 0.5×	225 0.7×	150 0.9×	58	1.3k

Countries citing papers authored by Anniina Snellman

Since Specialization

Citations

This map shows the geographic impact of Anniina Snellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anniina Snellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anniina Snellman more than expected).

Fields of papers citing papers by Anniina Snellman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anniina Snellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anniina Snellman. The network helps show where Anniina Snellman may publish in the future.

Co-authorship network of co-authors of Anniina Snellman

This figure shows the co-authorship network connecting the top 25 collaborators of Anniina Snellman. A scholar is included among the top collaborators of Anniina Snellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anniina Snellman. Anniina Snellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matilainen, Markus, Jouni Tuisku, Sauli Laaksonen, et al.. (2025). Synaptic Density in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(5). e200435–e200435.

Lantero‐Rodriguez, Juan, Gemma Salvadó, Anniina Snellman, et al.. (2024). Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease. Molecular Neurodegeneration. 19(1). 19–19. 13 indexed citations

Keller, Thomas H., Markus Matilainen, Jonathan J. Danon, et al.. (2024). Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA. EJNMMI Research. 14(1). 25–25. 4 indexed citations

Ekblad, Laura L., Juan Lantero‐Rodriguez, Nicholas J. Ashton, et al.. (2024). Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly. Alzheimer s Research & Therapy. 16(1). 112–112. 8 indexed citations

Saraste, Maija, Marjo Nylund, Rainer Hinz, et al.. (2024). Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals. Frontiers in Neurology. 15. 1352116–1352116. 6 indexed citations

Ekblad, Laura L., Virva Saunavaara, Semi Helin, et al.. (2024). Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET. Neurobiology of Disease. 192. 106439–106439. 4 indexed citations

Lantero‐Rodriguez, Juan, Cécile Tissot, Anniina Snellman, et al.. (2023). Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden. Alzheimer s & Dementia. 19(12). 5343–5354. 11 indexed citations

Lantero‐Rodriguez, Juan, Agathe Vrillon, Aida Fernández‐Lebrero, et al.. (2023). Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts. Alzheimer s Research & Therapy. 15(1). 48–48. 6 indexed citations

Snellman, Anniina, Laura L. Ekblad, Jouni Tuisku, et al.. (2023). APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly. Alzheimer s Research & Therapy. 15(1). 71–71. 13 indexed citations

10.

Snellman, Anniina, Laura L. Ekblad, Noora Lindgrén, et al.. (2022). ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics. Frontiers in Neurology. 13. 826423–826423. 9 indexed citations

11.

Heslegrave, Amanda, Nicholas J. Ashton, Thomas K. Karikari, et al.. (2021). Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Journal of Internal Medicine. 290(3). 583–601. 60 indexed citations

12.

Lantero‐Rodriguez, Juan, Anniina Snellman, Andréa L. Benedet, et al.. (2021). P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease. EMBO Molecular Medicine. 13(12). e15098–e15098. 30 indexed citations

13.

Rokka, Johanna, Francisco R. Lopez‐Picon, Anniina Snellman, et al.. (2021). (S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease. Neuropharmacology. 196. 108676–108676. 6 indexed citations

14.

Grothe, Michel J., Alexis Moscoso, Nicholas J. Ashton, et al.. (2021). Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy. Neurology. 97(12). e1229–e1242. 56 indexed citations

15.

Karikari, Thomas K., Andréa Lessa Benedet, Nicholas J. Ashton, et al.. (2020). Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative. Molecular Psychiatry. 26(2). 429–442. 218 indexed citations breakdown →

16.

Moscoso, Alexis, Michel J. Grothe, Nicholas J. Ashton, et al.. (2020). Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum. Brain. 144(1). 325–339. 142 indexed citations

17.

Lopez‐Picon, Francisco R., Anniina Snellman, Tove J. Grönroos, et al.. (2016). Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using ¹⁸F-GE-179 and ¹⁸F-GE-194 Autoradiography. Journal of Nuclear Medicine. 57(9). 1442–1447. 17 indexed citations

18.

Kõks, Sulev, Anniina Snellman, Merja Haaparanta‐Solin, et al.. (2016). Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese. Brain Research. 1652. 97–102. 2 indexed citations

19.

Snellman, Anniina, Francisco R. Lopez‐Picon, Johanna Rokka, et al.. (2013). Longitudinal Amyloid Imaging in Mouse Brain with ¹¹C-PIB: Comparison of APP23, Tg2576, and APP_swe-PS1_dE9 Mouse Models of Alzheimer Disease. Journal of Nuclear Medicine. 54(8). 1434–1441. 67 indexed citations

20.

Snellman, Anniina, Johanna Rokka, Francisco R. Lopez‐Picon, et al.. (2012). Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 39(11). 1784–1795. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact